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ABSTRACT
Clinical studies/trials are experiments or observations on human subjects considered by
the scientific community the most appropriate instrument to answer specific research
questions on interventions on health outcomes. The time-line of the observations
might be focused on a single time point or to follow time, backward or forward,
in the so called, respectively, retrospective and prospective study design. Since the
retrospective approach has been criticized for the possible sources of errors due to bias
and confounding, we aimed this study to assess if there is a prevalence of retrospective
vs. prospective design in the clinical studies/trials by querying MEDLINE. Our results
on a sample of 1,438,872 studies/trials, (yrs 1960–2017), support a prevalence of
retrospective, respectively 55% vs. 45%. To explain this result, a random sub-sample of
studies where the country of originwas reported (n= 1,576)was categorized in high and
low-income based onthe nominal Gross Domestic Product (GDP) and matched with
the topic of the research. As expected, the absolute majority of studies/trials are carried
on by high-income countries, respectively 86% vs. 14%; even if a slight prevalence
of retrospective was recorded in both income groups, for the most part prospective
studies are carried out by high-GDP countries, 85% vs. 15%. Finally, the differences in
the design of the study are understandable when considering the topic of the research.
Subjects Bioinformatics, Clinical Trials, Epidemiology, Statistics, Data Mining and Machine
Learning
Keywords Biological life, Clinical trials, Chronobiology, Clinical study, Disease, Retrospective
study, Time variable, Prospective study, MedLine, Aging, Demographic data, Bibliometric study
INTRODUCTION AND AIMS
We generally consider time as a quantity that in clinical studies/trials plays the role of
independent variable having, often, a real value on an axis of a graph; but time is just a
way to give order to changes and, in biology, time is essentially rhythm of changes, with
short and long cycles that are controlled by specific allocated resources that are the matter
of chronobiology (Goldbeter, 1996). Usually clinical studies/trials are focused on diseases
that are a common cause of chronodisruption at multiple levels (Oldham, Lee & Desan,
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2016), meaning that circadian rhythms are severely altered among the patients, depending
on the severity of the disease; this disruption expands from the cellular level, where the
genes that regulate the biological clock are expressed, up to the subjective perspective
of the patient including pain. These studies are generally aimed at identifying causes of
disease and to set up/verify possible strategies to prevent or care them (Friedman, Furberg
& DeMets, 2010). Usually the observation of the variable(s) under study is fixed on singular
time points or is followed backward or forward in the so called, respectively, retrospective
and prospective design of the study. In such view the availability of comprehensive clinical
databases, e.g., compiled during the hospitalization, allows the clinical researcher to force
easily backward the arrow of time in search of possible causal links. This approach, that is
undoubtedly cheaper, has often been criticized (Secrier & Schneider, 2014) for the possible
sources of errors due to bias and confounding, that are, indeed, more common if compared
with prospective studies (Mantel & Haenszel, 1959).
In order to evaluate the tendency of researchers to use a retrospective design in
studies/trials by turning backward the ‘‘arrow of time’’, in this study we firstly searched
MEDLINE and obtained the number of retrospective and prospective matching studies,
starting from 1960 to 31 December 2017, an interval that was considered representative
since, before 1960, very few studies are available. Secondly, in order to speculate on the
reasons of this choice, we randomly choose a sub-sample of studies, where the country of
origin of the first author was clearly stated, that was matched with the nominal Gross
Domestic Product (GDP) obtained from the World Economic Outlook (WEO) by
the International Monetary Fund (IMF) (World Economic and Financial Surveys, World
Economic Outlook Database, 2017). Thirdly, to evaluate the prevalence of retrospective
versus prospective studies in the different thematic areas, the results have been grouped
accordingly. Finally, in the discussion the conclusions are matched with the opinions
previously gathered through a random sample of researchers, matching as authors
of the papers retrieved, that were obtained by e-mailing, by using a published survey
questionnaire (Survey Monkeys, 2018).
METHODS
The MEDLINE database was queried through PubMed, the public access web portal
of the National Library of Medicine, National Institutes of Health-USA, in September
2017 by using the keywords ‘‘retrospective study’’ and ‘‘prospective study’’; these words
were assumed as reference to describe the two types of approach. For the purpose of this
research, after evaluating/comparing the possible strategies, including a comparison with
other databases such as EMBASE, (see also limitations of the study), in agreement with
our reference librarian, we relied on free text search by using the ‘‘best match’’, a function
available on PubMed (Fiorini et al., 2018) that includes MESH. The search string used was:
(retrospective study AND (‘‘1960/01/01’’[PDat]: ‘‘2017/12/31’’[PDat]))
(prospective study AND (‘‘1960/01/01’’[PDat]: ‘‘2017/12/31’’[PDat])).
For the general statistics, even if few matching records were found starting from 1913,
the ‘‘publication date’’ of the search query was limited by starting from 1960, where at least
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10 matching documents for both category were found. For the assessment of the country
of origin and topic, we randomly sampled a minimum of five studies per decade where the
country of origin of the first author was clearly stated and the topic was assessable by the
availability of a full text. Since in most cases it was not possible to find all the information
needed, this sample was built starting from 2004 and placed in a comprehensive database
including the over-mentioned variables.
Finally, we created two GDP-based macro-categories that permitted to distinguish
high-income countries of origin of the research from low ones; the cut-off for incomes
was >467,775 millions of US $; this arbitrary value, corresponding to 75% over the mean,
allowed to include a larger number of countries into the high-GDP with respect to other
criteria such as the G-7. Thus, the two GDP categories were matched with the topic of the
studies.
MMC and PV defined the search strategy, in agreement with our reference librarian (see
acknowledgments section), PV performed the search strategy. All the disagreements were
solved by carefully checking the search strategy previously.
RESULTS
The results support that, since the sixties, there are significant numerical differences with
a majority of retrospective studies. Out of a 1,438,872 matching records, 787,938 (55%)
were retrospective whereas 650,934 (45%) prospective. By examining the decades, this
trend began in 1960 and, except for the decade 1980–1990, is maintained and widen
considerably in the last years. Indeed, in the last 5 years 278,354 (58.6%) retrospective vs.
196,679 (41.4%) prospective studies were found, corresponding to a difference of +81,675
retrospective studies (Fig. 1). Furthermore, as stated in the methods section, even if the
search was limited to the interval 1960–2017, a difference is appreciable since the starting
coverage of the database; the keywords ‘‘retrospective study’’ appears for the first time in
1913 while ‘‘prospective study’’ in 1923, with only one matching document for each type
of study. This difference is also reproduced in the sub-sample (years 2004–2015) made
of 1,576 matching records, of which 903 (57%) were retrospective whereas 673 (43%)
prospective. The general prevalence of studies attributable to the high-GDP countries was
very high accounting for 86% of the total vs. 14%; this data support that conception,
realization of a clinical study/trial and access to publication is related to the GDP (Fig. 2).
Furthermore the 85% of prospective studies are ascribable to the high-GDP group while
only a 15% to the low-GDP, and this even if a prevalence of retrospective studies was
recorded in the high-GDP. Finally these differences are understandable when considering
the topic of the research that requires a specific design (Fig. 3).
DISCUSSION
Time is the most intriguing variable in the universe and, on earth, it affects irreversibly
biological life since every form of life has a non-zero probability of dying that increases
with the flow of time in a general process known as biological aging. Since it is impossible
to reverse the course of events, living organisms must adapt reproduction, development
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Figure 1 Number of matching documents retrieved fromMedLine years 1960–2017 by using the key-
words indicated in the method section. (A) Area graph showing the number of matching documents re-
trieved from MedLine years 1960–2017 by using the keywords indicated in the method section. On the x
axis are reported the decades starting from 1960, on the y axis, the absolute number of published papers.
(B) Pie chart reporting the percentage of retrospective and prospective studies.
Full-size DOI: 10.7717/peerj.6363/fig-1
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Figure 2 Pie chart showing the prevalence of Retrospective (A) vs. Prospective studies (B) in high and
low-GDP countries as retrieved fromMEDLINE.
Full-size DOI: 10.7717/peerj.6363/fig-2
Figure 3 Prevalence of the topic in the retrospective and prospective studies retrieved fromMedLine.
Bar chart showing the prevalence of the topic in the retrospective (A) and prospective studies (B) as re-
trieved from MedLine.
Full-size DOI: 10.7717/peerj.6363/fig-3
and evolution to cope time and its rhythms by committing specific biological resources
that are the matter of chronobiology, making time a measure of the cyclical and stochastic
changes in biology rather than an absolute physical quantity. Biological life with aging
is invariably associated with the experience of disease, whose incidence seems to be
ruled by chance (Ciulla, 2015b) but when clinical researchers study diseases, generally,
to preserve human life and avoid unnecessary suffering, what they actually do of the
time variable, namely, how the variables are followed, or sampled, in time, backward
or forward? Indeed any study on diseases might takes into account the ‘‘point of view’’
which might suggest misleading cause–effect relationship (Ciulla, 2015a). Even if the our
objective was not so ambitious to dismantle the mechanism of time in diseases, in the
present study, based on a MEDLINE search strategy starting from 1960, we highlighted
that, when studying disease, the preferred choice of the study design is the retrospective one
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and this is nontrivial as it allows us to make some considerations. We can assume that the
retrospective study design is prevalent in the scientific literature possibly since it represent:
(1) a cheaper approach to make forecasting on disease development, (2) an easy choice
because of the availability of clinical records or, simply, (3) a wrong choice due to lack
of statistical knowledge. These assumption are corroborated by the opinions of a random
sample of researchers, matching as authors of the papers retrieved, that were obtained by
e-mailing, previously, by using a published survey questionnaire (Survey Monkeys, 2018).
In particular, in choosing the retrospective design, the involved researchers feel that they
have been limited by the availability of funds and instead favored by the easy access to a
clinical database. Furthermore, the surveyed researchers believe that the prospective design
is more expensive, statistically appropriate and clinical predictable. At this regard, it should
be said that there is no direct evidence of the inferiority of retrospective studies if well
conducted (Nagurney et al., 2005); however, retrospective studies are limited by the level
of knowledge and availability of data at the time of collection, on the contrary, prospective
studies may, theoretically, incorporate any possible newer variable. These opinions are
supported by our results since the absolute majority of studies/trials are almost always
conducted by high-GDP countries and the 85% of prospective studies are ascribable to the
high-GDP group while only a 15% to the low-GDP. A further key can be found in the topic
of the studies/trials where most of prospective are associated with ‘‘cardiovascular’’, a topic
known to catalyze great investments from the pharmaceutical companies, and ‘‘surgery’’,
which benefits from a short-term prospective outcome.
CONCLUSIONS
In clinical studies/trials the time variable is fundamental in the design the study; by
analyzing MEDLINE database 1960–2017, we show that: 1—most of clinical studies/trial
use a retrospective design of the study even if there is no direct evidence of its superiority
if compared to the prospective one, on the other hand, there are no evidence of an
intrinsic inferiority of the retrospective design in statistical precision and in clinical
predictability (Nagurney et al., 2005); 2—most of prospective studies were conducted by
high-GDP countries supporting that the cost is, as expected, one of the main constraints
and this possibly concerns the cost of research, as also highlighted by other studies, of some
years ago, on imbalance in health research resources (Barreto Mauricio, 2009) and on the
consequences of globalization of clinical research (Glickman et al., 2009); and 3—some
research topics are more frequently associated with the perspective design and this may be
linked, possibly, to the availability of funds and the need of a specific short-term design of
the study.
LIMITATIONS
This study has several limitations that should be acknowledged, Firstly, the key words
retrospective and prospective are assumed as reference to describe two approaches in setting
up a clinical study/research and this may results in some imprecisions due to a broad use of
these terms; in this regard, the long lasting use of this terminology confirms their established
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semantic use. Secondly, bibliometric methods examine a body of work at a macro level and
our results must be interpreted in light of this. Using a simple search has the benefits of
being readily understood and easily replicated but inevitably produces some imprecision
or noise. In our study 93% of prospective studies and 95% of retrospective studies were
indexed as human, some were index as animal studies, some were indexed as both human
and animal studies, and some were indexed as neither. In any case, these studies have been
classified this way according toMESH and, therefore, included in the results of the research
which was conducted with a correct syntax. Also, about 8% of prospective studies were also
retrieved by the search for retrospective studies and are included in both analyses; thirdly,
MEDLINE is constantly expanding thus our study represents a partial view over a rather
long time interval. Finally, by focusing on the first author, we emphasized the authorship
by losing the opportunity to highlight international collaborations.
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